AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain ...
AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early ...
News-Medical.Net on MSN
Oral combination regimen Improves survival in ER-positive HER-2-negative breast cancer
Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback